Nuclear <scp>pCHK1</scp> as a potential biomarker of increased sensitivity to <scp>ATR</scp> inhibitionVignesh Sundararajan(University Medical Center Freiburg), David S.P. Tan(National University of Singapore)The Journal of PathologyNovember 14, 202210.1002/path.6032Cited by 9SaveCiteExport RISWatch citationsRelated PapersThe ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5|Oncotarget|2015|68